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Despite recent efforts to enforce policies requiring the sharing of data underlying clinical findings, current policies
of biomedical journals remain largely heterogeneous. As this heterogeneity does not optimally serve the cause of
data sharing, a first step towards better harmonization would be the requirement of a data sharing statement for all
clinical studies and not simply for randomized studies. Although the publication of a data sharing statement does
not imply that all data is made readily available, such a policy would swiftly implement a cultural change in the
definition of scientific outputs. Currently, a scientific output only corresponds to a study report published in a
medical journal, while in the near future it might consist of all materials described in the manuscript, including all
relevant raw data. When such a cultural shift has been achieved, the logical conclusion would be for biomedical
journals to require authors to make all data fully available without restriction as a condition for publication.
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Background
The recently released US Institute of Medicine (IOM)
report [1] on clinical data sharing has stimulated a wide-
ranging discussion on the benefits and harms associated
with the unrestricted availability of all data underlying
clinical findings [2, 3]. The IOM concluded that the
benefits of sharing outweigh the risks, and made sugges-
tions for further improvement. Further, the report urged
biomedical journals, as evaluators and publishers of
research results and implementers of academic stan-
dards, to enforce policies that require the sharing of
clinical trial data [1]. In response to this, in 2016, the
International Committee of Medical Journal Editors
(ICMJE) proposed the requirement that de-identified
individual patient data underlying the results presented in
a given article should be provided as a condition for con-
sideration of publication of a clinical trial report [4].
As a practical contribution to this challenging debate,
the present commentary aims to raise awareness on the
current data sharing policies of biomedical journals. As
an example, the instructions for authors of the top ten
general and internal medical journals according to
impact factor were inspected, and information on data
sharing requirements were abstracted and summarized.
Current data sharing policies of biomedical
journals
The top ten general and internal medicine journals ac-
cording to impact factor currently implement three
different data sharing approaches (Table 1). A first group
of journals, including the New England Journal of
Medicine, The Lancet, JAMA, JAMA Internal Medicine,
Journal of Cachexia and Sarcopenia, and Mayo Clinic
Proceedings, do not mention data sharing, do not require
any statement to be published along with the study re-
port on the possibility to access the raw data, and do not
suggest repositories or other tools to make the raw data
available. A second group of journals, including Annals
of Internal Medicine, BMJ, and BMC Medicine, encour-
age data sharing and require a formal statement de-
scribing the conditions under which raw data are
accessible. Additionally, from July 1, 2015, the BMJ re-
quires that all submitted clinical trials include a dec-
laration of data sharing upon request [5]. Finally, a
third policy is implemented by PLoS Medicine, requir-
ing full availability of all data underlying the findings
described in published study reports (Table 1). In gen-
eral, journals recommending or requiring data sharing
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also suggest repositories and other tools to make the
raw data available.
Towards a new sharing culture
Current diversity in journal policies does not optimally
serve the cause of data sharing as it allows varying
academic standards. Through this system, study authors
are able to choose their standard of preference when
submitting a study report – a decision which might be
guided, among other considerations, by their willingness
to share.
As a first step towards better harmonization, biomed-
ical journals should require a data sharing statement for
all types of clinical study reports, and not simply for ran-
domized studies. If audit and accountability are the
‘bread and butter’ of good medicine and science [6],
accepting various policies for different clinical study
types would imply that studies with an observational
design are not good science.
Even if publishing a data sharing statement does not
mean making all data available, such a policy would swiftly
implement a cultural change in the definition of scientific
outputs. Currently, a scientific output only corresponds to
a study report published in a medical journal, while in the
near future it might consist of all materials described in
the manuscript, including all relevant raw data.
With such a policy uniformly implemented, re-
searches, who are currently interested in designing and
conducting studies with the aim of meeting the highest
methodological standards and requirements to ensure
publication in major medical journals, would consider
the issue of data sharing from the inception of their re-
search projects. This would imply, for example, (1) the
inclusion of a data sharing plan as part of a study proto-
col and its registration in international repositories of
study protocols [7]; (2) agreement with local ethics com-
mittees on a procedure to preserve patient confidential-
ity and privacy when de-identified individual patient
data are shared [8, 9]; (3) the inclusion of financial sup-
port for data sharing in grant applications; (4) drafting
of a detailed publication plan in order to allow the best
use of the database [10]; and, even more importantly,
(5) the development of a high-quality database in a
way suitable for secondary uses, written and coded in
English, for example, but also meeting other require-
ments that expert methodologists would need to fur-
ther develop and define [11]. There should also be
careful development of web-based infrastructures for
open data, as it would be rather disappointing if the
promising development of open sharing of data led to
no more than researchers piling their data in fairly
unsearchable data repositories [12, 13]. Additionally,
reporting guidelines, such as the CONSORT for clin-
ical trials, PRISMA for systematic reviews of clinical
trials, STROBE for observational studies, and MOOSE
for systematic reviews of observational studies, would
need to be updated by adding items for proper data
sharing plans (what to share, when, and how) [7].
This policy would make data sharing the norm, with
some reasonable exceptions that authors may publicly
declare in their data sharing statement [14]. As the ma-
jority of published studies are not clinical trials, but ra-
ther studies with an observational design, it may be
expected that most researchers would easily adhere to
the spirit and practicalities of data sharing. Paradoxically,
therefore, observational rather than randomized data
Table 1 Data sharing requirements of the top ten general and internal medicine journals
Journal Data sharing Data sharing
statement
Data repositories
suggestedNot mentioned Suggested Required
New England Journal of Medicine X No No
The Lancet Xa No No
JAMA X No No
Annals of Internal Medicine Xb Yes No
BMJ Xc Yes Yes
PLoS Medicine Xd Yes Yes
JAMA Internal Medicine X No No
Journal of Cachexia and Sarcopenia X No No
BMC Medicine Xe Yes Yes
Mayo Clinic Proceedings X No No
a Authors may be required to provide the raw data for research papers when they are under review and up to 10 years after publication in The Lancet
b Annals of Internal Medicine encourages but does not typically require the sharing of the raw data. However, it requires that authors state their willingness to
share and any conditions for sharing
c For all trials, the BMJ requires data sharing on request as a minimum
d PLoS Medicine requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception
e BMC Medicine strongly encourages that all datasets on which the conclusions of the paper rely should be made available to readers.
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may pave the way towards full implementation of a data
sharing culture.
Conclusions
When such a cultural shift has been achieved, the logical
conclusion would be for biomedical journals to require
authors to make all data fully available without restric-
tion as a condition for publication. In 2004, the ICMJE
announced that it would require registration of clinical
trials as a condition for publication, with a remarkable
effect in clinical trial research [15]. If the top-ranking
biomedical journals, for example those belonging to the
ICMJE, were to find a consensus on these steps and
homogenize their standards on data sharing for all types
of clinical studies, then the remaining journals would
certainly follow.
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